Plain-English translation of NCT07329257 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Project PENGUIN is a research study investigating rare genetic disorders that affect brain development and function—conditions like Baker-Gordon Syndrome and other neurodevelopmental disorders caused by gene mutations. The study collects information about symptoms, takes skin biopsies, and gathers data from both affected individuals and their caregivers to help researchers understand how these rare conditions work and develop better treatments in the future.
These rare genetic brain disorders are poorly understood because they affect so few people, making it hard for doctors to recognize patterns and develop effective treatments. This study aims to fill that gap by systematically collecting information over time to understand how symptoms change, what biological markers exist, and how to design better therapies.
You likely qualify if…
You likely don't qualify if…
Participants will visit the research team for evaluations where they will answer questions about symptoms and medical history, and may have a small skin biopsy taken (with numbing medication) if they qualify. Caregivers of affected individuals will also be asked to participate. The study will track how symptoms evolve over time, with visits scheduled according to the research team's protocol.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States